Publikationen, an denen er mitarbeitet FÁTIMA CANO CANO (22)

2024

  1. Arylphthalide Delays Diabetic Retinopathy via Immunomodulating the Early Inflammatory Response in an Animal Model of Type 1 Diabetes Mellitus

    International Journal of Molecular Sciences, Vol. 25, Núm. 15

  2. Bilateral primary motor area intermittent theta-burst stimulation may alleviate gait and postural disturbances in Parkinson's disease patients by astrocytic modulation, caudate volume changes, and increased functional neuroplasticity

    Parkinsonism and Related Disorders

  3. Retinal dysfunction in Huntington’s disease mouse models concurs with local gliosis and microglia activation

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. Hippocampal subfield abnormalities and biomarkers of pathologic brain changes: from SARS-CoV-2 acute infection to post-COVID syndrome

    eBioMedicine, Vol. 94

  2. Intermittent theta burst stimulation to the primary motor cortex promotes symptomatic alleviation of non-motor symptoms in Parkinson’s disease

    Brain Stimulation, Vol. 16, Núm. 1, pp. 361-362

  3. MRI and serum NfL/GFAP predictors of cognitive and clinical decline in newly diagnosed relapsing remitting multiple sclerosis patients: a 3-year follow-up study.

    MSMilan 2023

  4. Marked improvement of postural and gait disturbances in Parkinson’s disease with bilateral primary motor area intermittent theta-burst stimulation may be linked to increased putamen-cortico-cerebellar functional connectivity: a case report

    Brain Stimulation, Vol. 16, Núm. 1, pp. 271-272

  5. Neuroimaging and serum biomarkers of neurodegeneration and neuroplasticity in Parkinson’s disease patients treated by intermittent theta-burst stimulation over the bilateral primary motor area: a randomized, double-blind, sham-controlled, crossover trial study

    Frontiers in Aging Neuroscience, Vol. 15

  6. Short-term effects of subthalamic deep brain stimulation on clinical symptoms and biomarkers of neurodegeneration in Parkinson's disease

    Brain Stimulation, Vol. 16, Núm. 1, pp. 304

2022

  1. A New Perspective on Huntington’s Disease: How a Neurological Disorder Influences the Peripheral Tissues

    International Journal of Molecular Sciences, Vol. 23, Núm. 11

  2. Adult kidney explants is a physiologic model for studying diabetic nephropathy

    Life Sciences, Vol. 300

  3. IL-1β Implications in Type 1 Diabetes Mellitus Progression: Systematic Review and Meta-Analysis

    Journal of Clinical Medicine, Vol. 11, Núm. 5

  4. Is mouse retinal affectation by HTT cag expansion suitable for modelling the neuroinflammatory component of Huntington’s disease?

    B: Models for HD

  5. Synthesis and Antioxidant/Anti-Inflammatory Activity of 3-Arylphthalides

    Pharmaceuticals, Vol. 15, Núm. 5

  6. Unravelling the Inflammatory Processes in the Early Stages of Diabetic Nephropathy and the Potential Effect of (Ss)-DS-ONJ

    International journal of molecular sciences, Vol. 23, Núm. 15

2021

  1. 1-year follow-up of subthalamic stimulation in Parkinson disease: neurodegeneration and motor/non-motor outcomes

    7th Congress of the European Academy of Neurology

  2. Anti-Inflammatory (M2) Response Is Induced by a sp2-Iminosugar Glycolipid Sulfoxide in Diabetic Retinopathy

    Frontiers in Immunology, Vol. 12

  3. Cortical Thickness and Serum NfL Explain Cognitive Dysfunction in Newly Diagnosed Patients With Multiple Sclerosis

    Neurology(R) neuroimmunology & neuroinflammation, Vol. 8, Núm. 6

  4. Immunomodulation of Microglia/Macrophage Interaction and its Effect in Diabetic Retinopathy Progression

    Meeting of the European Association for the Study of Diabetes Eye Complications Study Group (EASDec), Vol. 31, Núm. 2_suppl, pp. 1-41

2020

  1. Cortical thickness and serum neurofilament light chain levels predict subtle neuropsychological impairment at early stages of Multiple Sclerosis

    6th Congress of the European Academy of Neurology